The uncertain macroeconomic environment has forced Life Science REIT to halve its 2023 dividend, as its portfolio valuation slumped.
In its annual results published today (26 March), the board of the £321m trust said it had decided to rebase the dividend to 2p per share, down from 4p in 2022. The directors said the decision to slash the dividend to a level that is "sustainable and substantially covered" by adjusted earnings over time was made in the context of continuing "macroeconomic uncertainty" and interest rates expected to remain elevated. Janus Henderson opens Global Life Sciences Strategy to UK clients "The additional financial flexibility will enable the group to effectively progress its strategy to d...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
